Achieve and maintain ROE of 20%, sales of ¥5 billion, and operating profit of ¥2 billion by the fiscal year ending May 2026
First written in FY2022. 2 of 5 entries say "Raised", first in 2026-06-25. Latest entry: 2026-09-29.
The whole theme swung hardest in 2021: 5 of 21 companies on the "Worse" side.
13 other companies' latest entry also says "Restated".
- 2026-09-29RestatedManagement plan
「For the fiscal year ending May 2028, the Company has set targets of: revenue of ¥8 billion (with a certain contribution expected from M&A); operating profit of ¥3 billion (with no contribution from M&A expected because of anticipated amortization and other expenses associated with M&A); and ROE of at least 30%.」
The Company reaffirmed targets of ¥8 billion in revenue, ¥3 billion in operating profit and ROE of at least 30% for the fiscal year ending May 2028 as the central objectives of its business plan. - FY2026RaisedAnnual report
「For the fiscal year ending May 2028, the Company has set numerical targets of net sales of ¥8,000 million, operating income of ¥3,000 million and ROE of 30% or higher, and aims to achieve further growth.」
While the former medium-term targets for the fiscal year ending May 2025 fell short at net sales of ¥4,800 million and operating income of ¥1,800 million, the Company set higher new targets for the fiscal year ending May 2028 of net sales of ¥8 billion, operating income of ¥3 billion and ROE of 30% or higher. - 2026-06-25RaisedRevision of earnings forecasts
「The Group announced medium-term targets of ¥8 billion in revenue and ¥3 billion in operating profit by the fiscal year ending May 2028.」
The Company presented updated medium-term targets, extending the deadline and raising the target levels from the previous targets of ¥5 billion in revenue and ¥2 billion in operating profit by the fiscal year ending May 2026. - FY2024SoftenedAnnual report
「The Company had aimed to achieve its medium-term targets of maintaining ROE at 20% and achieving net sales of ¥5,000 million and operating income of ¥2,000 million in the fiscal year ending May 2025. However, profitability deteriorated mainly in part of the DX business, and the Company downsized the business in response. As a result, its forecast for the fiscal year ending May 2025 is net sales of ¥4,580 million and operating income of ¥1,800 million, and it expects not to reach the medium-term targets.」
The target of achieving ROE of 20%, net sales of ¥5 billion and operating income of ¥2 billion in the fiscal year ending May 2025 was lowered to a forecast of net sales of ¥4.58 billion and operating income of ¥1.8 billion due to deteriorating profitability in the DX business and business downsizing, with the shortfall explicitly projected. - FY2022First statedAnnual report
「The Company's medium-term targets were to maintain ROE at 20% and achieve net sales of ¥5,000 million and operating income of ¥2,000 million by the fiscal year ending May 2026. However, with the expansion of the corporate group, the Company aims to achieve these targets more than 1 year ahead of schedule. Toward achieving these targets, the Company has set its earnings forecast for the fiscal year ending May 2023 at net sales of ¥3,681 million.」
The Company presented a new medium-term policy, distinct from its previous target of a net sales CAGR above 30%, to maintain ROE at 20% and achieve net sales of ¥5 billion and operating income of ¥2 billion by the fiscal year ending May 2026, with the aim of bringing achievement forward by more than 1 year.